Jennifer Marks

Summary

Affiliation: University of Miami
Country: USA

Publications

  1. ncbi request reprint Perioperative management of diabetes
    Jennifer B Marks
    Department of Medicine, University of Miami School of Medicine, Miami, Florida 33136, USA
    Am Fam Physician 67:93-100. 2003
  2. doi request reprint Insulin analogues
    Jennifer Marks
    University of Miami School of Medicine, Miami, FL 33136, USA
    Postgrad Med 112:8-12. 2002
  3. ncbi request reprint Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study
    Philip Raskin
    University of Texas, Southwestern Medical Center, Dallas, Texas 75390 8858, USA
    Diabetes Care 26:2598-603. 2003

Research Grants

  1. Diabetes TrialNet
    Jennifer Marks; Fiscal Year: 2007

Detail Information

Publications3

  1. ncbi request reprint Perioperative management of diabetes
    Jennifer B Marks
    Department of Medicine, University of Miami School of Medicine, Miami, Florida 33136, USA
    Am Fam Physician 67:93-100. 2003
    ..Frequent monitoring of electrolytes and acid-base status is important during the perioperative period, especially in patients with type 1 diabetes because ketoacidosis can develop at modest levels of hyperglycemia...
  2. doi request reprint Insulin analogues
    Jennifer Marks
    University of Miami School of Medicine, Miami, FL 33136, USA
    Postgrad Med 112:8-12. 2002
    ..The long-acting analogues, such as insulin glargine and insulin detemir, mimic the insulin secretory profile of basal insulin. Together, they approximate physiologic insulin secretion...
  3. ncbi request reprint Continuous subcutaneous insulin infusion and multiple daily injection therapy are equally effective in type 2 diabetes: a randomized, parallel-group, 24-week study
    Philip Raskin
    University of Texas, Southwestern Medical Center, Dallas, Texas 75390 8858, USA
    Diabetes Care 26:2598-603. 2003
    ..Compare the efficacy, safety, and patient satisfaction of continuous subcutaneous insulin infusion (CSII) therapy with multiple daily injection (MDI) therapy for patients with type 2 diabetes...

Research Grants1

  1. Diabetes TrialNet
    Jennifer Marks; Fiscal Year: 2007
    ..If not prevented, a treatment effect that preserves beta-cell function in those who do develop diabetes will provide an important clinical benefit. ..